Related Experiment Video
Updated: Apr 16, 2026
03:23
Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
Published on: May 10, 2024
1.6K
Biologic therapies targeting eosinophils: current status and future prospects.
1Human Eosinophil Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda.
The Journal of Allergy and Clinical Immunology. in Practice
|March 11, 2015
Summary
The growing number of biologic therapies for eosinophilic disorders presents treatment challenges. This review examines anti-interleukin-5 (IL-5) antibodies and novel targeted therapies for better patient selection.
Area of Science:
- Immunology
- Pharmacology
- Pulmonology
Background:
- Eosinophilic disorders are increasingly treated with biologic therapies.
- The expanding therapeutic landscape necessitates careful patient-specific treatment selection.
- First-generation eosinophil-targeted biologics include anti-interleukin-5 (IL-5) antibodies.
Purpose of the Study:
- To review lessons learned from clinical trials of anti-IL-5 antibodies.
- To discuss current and emerging targeted therapies for eosinophilic disorders.
- To guide the selection of appropriate biologic agents for individual patients.
Main Methods:
- Literature review of clinical trials.
- Analysis of data from first-generation biologics (anti-IL-5 antibodies).
- Discussion of advantages and limitations of existing and novel therapies.
Main Results:
- Clinical trials provide valuable insights into the efficacy and safety of anti-IL-5 antibodies.
- A range of targeted therapies are available and in development for eosinophilic disorders.
- Understanding therapy profiles is crucial for optimizing treatment selection.
Conclusions:
- Lessons from anti-IL-5 antibody trials inform current practice.
- Novel targeted therapies offer new options but require careful consideration.
- Personalized medicine approaches are essential for managing eosinophilic disorders effectively.
Related Concept Videos
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.4K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K
01:19Antiasthma Drugs: Leukotriene Modifiers
2.3K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
2.3K
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.6K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.6K
01:30Asthma-IV: Diagnostic and Management
3.4K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.4K
02:57Targeted Cancer Therapies
9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.2K
01:20Asthma: Pathogenesis and Management
1.7K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K